Johnson & Johnson (JNJ) is a publicly traded Healthcare sector company. As of September 14, 2026, JNJ trades at $268.96 with a market cap of $640.02B and a P/E ratio of 30.52. JNJ moved +1.27% today. Year to date, JNJ is +28.36%; over the trailing twelve months it is +48.78%. Its 52-week range spans $141.50 to $281.07. Analyst consensus is strong buy with an average price target of $286.61. Rallies surfaces JNJ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Johnson & Johnson (JNJ) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. JNJ moved +1.27% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $268.96 |
| Market Cap | $640.02B |
| P/E Ratio | 30.52 |
| EPS | $8.73 |
| Dividend Yield | 1.34% |
| 52-Week High | $281.07 |
| 52-Week Low | $141.50 |
| Volume | 6.89K |
| Avg Volume | 0 |
| Revenue (TTM) | $97.93B |
| Net Income | $21.04B |
| Gross Margin | 67.91% |
18 analysts cover JNJ: 0 strong buy, 14 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $286.61.